Asia Pacific Amniotic Membrane Market Growth and Recent Trends by 2027

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

Asia Pacific Amniotic Membrane Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Enzyme (Cryopreserved Amniotic Membrane, and Dehydrated Amniotic Membrane); Application (Surgical Wounds, Ophthalmology, and Others); End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Research Institute and Academic Institutes), and Country

  • Report Date : Sep 2020
  • Report Code : TIPRE00014179
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 69
Page Updated: Dec 2020

The Asia-Pacific amniotic membrane market was valued at US$ 279.28 million in 2019 and is projected to reach US$ 503.69 million by 2027; it is expected to grow at a CAGR of 7.8% during the forecast period.

The growth of the Asia Pacific amniotic membrane market is estimated to grow due to growing applications of amniotic membrane and rising number of target patient population. However, challenges in using amniotic membranes are likely to restraint the market growth during the forecast period

Amniotic membrane transplantation technique has brought revolutionary changes in reconstructive surgery of the eyes. the process of product approvals has been accelerating in the developed markets. Fast FDA approvals for amniotic membrane-based products such as suspensions and allografts to treat surgical wounds contribute to the growth of the amniotic membrane market. Factors such as rising R & D investments in stem cell and regenerative medicine using cryotek processes fuel market growth. In the coming years, the market for the amniotic membrane will develop significantly in the Asia Pacific region due to the rise in the patient population, and the increase in healthcare spending. Most of the countries in this region are economically developing disposable income gradually. Many multinational companies are heavily investing in this region, and the rising number of AMT procedures in India and China are supporting growth.

Indian Council of Medical Research (ICMR), World Health Organization (WHO), and National Hospital Ambulatory Medical Care are some of the major primary and secondary sources for the Amniotic membrane market included in the report.

Asia Pacific Amniotic Membrane Market Revenue and Forecast to 2027 (US$ Mn)

13792-img1
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

ASIA PACIFIC AMNIOTIC MEMBRANE MARKET SEGMENTATION

Amniotic Membrane Market– By Enzyme

  • Cryopreserved Amniotic Membrane
  • Dehydrated Amniotic Membrane

Amniotic Membrane Market– By Application

  • Surgical Wounds
  • Ophthalmology
  • Others

Amniotic Membrane Market – By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Speciality Clinics
  • Research Institute and Academic Institutes

Amniotic Membrane Market - By Country

  • China
  • Japan
  • India
  • Australia
  • South Korea

Company Profiles

  • Amniox Medical, inc
  • Integra Life Sciences Corporation
  • MiMedx
  • Organogenesis Inc.
  • Smith & Nephew

Asia Pacific Amniotic Membrane Report Scope

Report Attribute Details
Market size in 2019 US$ 279.28 Million
Market Size by 2027 US$ 503.69 Million
Global CAGR (2019 - 2027) 7.8%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Enzyme
  • Cryopreserved Amniotic Membrane
  • Dehydrated Amniotic Membrane
By Application
  • Surgical Wounds
  • Ophthalmology
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Research Institute and Academic Institutes
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Amniox Medical, inc
  • Integra Life Sciences Corporation
  • MiMedx
  • Organogenesis Inc.
  • Smith & Nephew
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Our Clients
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Email: sales@theinsightpartners.com
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
ISO Certified Logo